• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢病毒载体介导的克隆追踪揭示了人类造血干细胞区室的内在异质性以及培养诱导的干细胞损伤。

Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment.

作者信息

Mazurier Frederic, Gan Olga I, McKenzie Joby L, Doedens Monica, Dick John E

机构信息

Division of Cell and Molecular Biology, University Health Network, Ste 7-700, 620 University Ave, Toronto, ON, Canada M5G 2C1.

出版信息

Blood. 2004 Jan 15;103(2):545-52. doi: 10.1182/blood-2003-05-1558. Epub 2003 Sep 22.

DOI:10.1182/blood-2003-05-1558
PMID:14504079
Abstract

Knowledge of the composition and interrelationship of the various hematopoietic stem cells (HSCs) that comprise the human HSC pool and the consequence of culture on each class is required for effective therapies based on stem cells. Clonal tracking of retrovirally transduced HSCs in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice revealed heterogeneity in the repopulation capacity of SCID-repopulating cells (SRCs). However, it is impossible to establish whether HSC heterogeneity is intrinsic or whether the culture conditions required for retroviral transduction induce qualitative and quantitative alterations to SRCs. Here, we report establishment of a clonal tracking method that uses lentivectors to transduce HSCs with minimal manipulation during overnight culture without cytokine stimulation. By serial bone marrow (BM) sampling of mice receiving transplants, short-term SRCs (ST-SRCs) and long-term SRCs (LT-SRCs) were identified on the basis of repopulation dynamics demonstrating that their existence is not an experimental artifact but reflects the state of the HSC pool. However, 4 days of culture in conditions previously used for SRC retroviral transduction significantly reduced SRC number as assessed by clonal analysis. These studies provide a foundation to understand the molecular and cellular determinants of human HSC development and to develop therapies targeted to specific HSC classes.

摘要

基于干细胞的有效治疗需要了解构成人类造血干细胞(HSC)库的各种造血干细胞的组成和相互关系,以及培养对每一类细胞的影响。在非肥胖糖尿病/严重联合免疫缺陷(NOD/SCID)小鼠中对逆转录病毒转导的造血干细胞进行克隆追踪,揭示了严重联合免疫缺陷重建细胞(SRC)的重建能力存在异质性。然而,无法确定造血干细胞的异质性是内在的,还是逆转录病毒转导所需的培养条件会导致SRC发生定性和定量的改变。在此,我们报告了一种克隆追踪方法的建立,该方法使用慢病毒载体在无细胞因子刺激的过夜培养过程中以最少的操作转导造血干细胞。通过对接受移植小鼠的连续骨髓(BM)采样,根据重建动力学确定了短期SRC(ST-SRC)和长期SRC(LT-SRC),这表明它们的存在并非实验假象,而是反映了造血干细胞库的状态。然而,通过克隆分析评估,在先前用于SRC逆转录病毒转导的条件下培养4天会显著减少SRC数量。这些研究为理解人类造血干细胞发育的分子和细胞决定因素以及开发针对特定造血干细胞类别的治疗方法奠定了基础。

相似文献

1
Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment.慢病毒载体介导的克隆追踪揭示了人类造血干细胞区室的内在异质性以及培养诱导的干细胞损伤。
Blood. 2004 Jan 15;103(2):545-52. doi: 10.1182/blood-2003-05-1558. Epub 2003 Sep 22.
2
Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells.在NOD-SCID小鼠股骨内移植后快速的髓系红细胞系重建揭示了一类新的人类干细胞。
Nat Med. 2003 Jul;9(7):959-63. doi: 10.1038/nm886.
3
Distinct classes of human stem cells that differ in proliferative and self-renewal potential.具有不同增殖和自我更新潜能的不同类别人类干细胞。
Nat Immunol. 2001 Jan;2(1):75-82. doi: 10.1038/83199.
4
Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient.慢病毒基因转移与人类原始干细胞的体外扩增,这些干细胞能够在NOD/SCID小鼠中实现一级、二级和三级多谱系重建。非肥胖糖尿病/严重联合免疫缺陷。
Blood. 2002 Dec 15;100(13):4391-400. doi: 10.1182/blood.V100.13.4391.
5
Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis.慢病毒载体转导NOD/SCID重建造血细胞会导致每个转导细胞出现多个载体整合:存在插入诱变的风险。
Blood. 2003 Feb 15;101(4):1284-9. doi: 10.1182/blood-2002-07-2238. Epub 2002 Oct 17.
6
Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation.通过NOD/SCID移植检测发现,血管生成素样蛋白5和胰岛素样生长因子结合蛋白2可刺激人脐带血造血干细胞的体外扩增。
Blood. 2008 Apr 1;111(7):3415-23. doi: 10.1182/blood-2007-11-122119. Epub 2008 Jan 17.
7
In vivo dynamics of human cord blood-derived CD34(-) SCID-repopulating cells using intra-bone marrow injection.经骨髓内注射研究人脐血源 CD34(-)SCID 重建细胞的体内动力学。
Leukemia. 2010 Jan;24(1):162-8. doi: 10.1038/leu.2009.206. Epub 2009 Oct 1.
8
Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors.使用第三代慢病毒载体转导人CD34+ CD38-骨髓及脐血来源的重症联合免疫缺陷病(SCID)重建细胞
Mol Ther. 2000 Jun;1(6):566-73. doi: 10.1006/mthe.2000.0077.
9
Characterization of cord blood hematopoietic stem cells.
Ann N Y Acad Sci. 2003 May;996:67-71. doi: 10.1111/j.1749-6632.2003.tb03234.x.
10
Cytokines, including stem cell factor alone, enhance lentiviral transduction in nondividing human LTCIC and NOD/SCID repopulating cells.细胞因子,包括单独的干细胞因子,可增强非分裂人类长期培养起始细胞(LTCIC)和NOD/SCID重建造血细胞中的慢病毒转导。
Mol Ther. 2003 Mar;7(3):325-33. doi: 10.1016/s1525-0016(03)00005-4.

引用本文的文献

1
Mapping Hematopoietic Fate after Transplantation.移植后造血命运图谱
Stem Cell Rev Rep. 2025 Aug 20. doi: 10.1007/s12015-025-10946-0.
2
A mixed-effects stochastic model reveals clonal dominance in gene therapy safety studies.混合效应随机模型揭示基因治疗安全性研究中的克隆优势。
BMC Bioinformatics. 2023 Jun 2;24(1):228. doi: 10.1186/s12859-023-05269-1.
3
An improved medium formulation for efficient gene editing, expansion and engraftment of hematopoietic stem and progenitor cells.一种用于造血干细胞和祖细胞高效基因编辑、扩增及植入的改良培养基配方。
Mol Ther Methods Clin Dev. 2023 Feb 28;29:58-69. doi: 10.1016/j.omtm.2023.02.014. eCollection 2023 Jun 8.
4
Normalization of clonal diversity in gene therapy studies using shape constrained splines.利用形状约束样条对基因治疗研究中的克隆多样性进行归一化。
Sci Rep. 2022 Mar 9;12(1):3836. doi: 10.1038/s41598-022-05837-0.
5
Therapy Development by Genome Editing of Hematopoietic Stem Cells.造血干细胞基因组编辑的治疗开发。
Cells. 2021 Jun 14;10(6):1492. doi: 10.3390/cells10061492.
6
Hematopoietic Stem Cells: Uncomfortable Considerations.造血干细胞:令人不安的思考
Curr Mol Biol Rep. 2017 Sep;3(3):165-171. doi: 10.1007/s40610-017-0068-4. Epub 2017 Jul 29.
7
The transformative potential of HSC gene therapy as a genetic medicine.造血干细胞基因治疗作为一种基因医学的变革潜力。
Gene Ther. 2023 Apr;30(3-4):197-215. doi: 10.1038/s41434-021-00261-x. Epub 2021 May 26.
8
Gene therapy using haematopoietic stem and progenitor cells.利用造血干细胞和祖细胞进行基因治疗。
Nat Rev Genet. 2021 Apr;22(4):216-234. doi: 10.1038/s41576-020-00298-5. Epub 2020 Dec 10.
9
Engineering monocyte/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing.利用基因组编辑技术在人造血干细胞中工程化表达单核细胞/巨噬细胞特异性葡萄糖脑苷脂酶。
Nat Commun. 2020 Jul 3;11(1):3327. doi: 10.1038/s41467-020-17148-x.
10
Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes.白藜芦醇三聚体通过降低内体中的抗病毒限制来增强向造血干细胞的基因传递。
Blood. 2019 Oct 17;134(16):1298-1311. doi: 10.1182/blood.2019000040.